Pharmaceutical Sales Jobs for the United States

Welcome to our Pharmaceutical Sales Jobs site. The purpose of this site is to provide a frequently updated list of current open positions for the pharmaceutical sales representative. Our focus is on pharmaceutical sales jobs which are available in the United States.

It also should be noted that a professionally written resume will give you that competitive edge, which is needed in a tough job market. For a professionally written resume at a reasonable price, take a look here. This company is one of the leading resume writing services in the US according to the Washington Post, and is definitely worth a look.

The following data should be interesting to the pharmaceutical sales rep who resides within the United States. This data comes from the Bureau of Labor Statistics.

Employment Statistics for the Sales Representative – Technical and Scientific Products (Includes Pharmaceutical Products)

States with the highest concentration of sales reps (technical and scientific products) with annual salary:
(highest at top)

New Hampshire $77,120
Massachusetts $88,550
Utah $74,800
South Dakota $63,310
Arizona $61,560

Top paying states with annual salary:
(highest at top)

Delaware $91,220
Massachusetts $88,550
Maryland $85,790
Minnesota $85,090
District of Columbia $85,050

Mean annual salary:

$76,460

Metropolitan areas with the highest concentration of sales representatives (technical and scientific products) with annual salary:

Nashua, NH-MA NECTA Division $78,780
Framingham, MA NECTA Division $74,970
Lowell-Billerica-Chelmsford, MA-NH NECTA Division $99,010
San Jose-Sunnyvale-Santa Clara, CA $100,000
Lake County-Kenosha County, IL-WI Metropolitan Division $88,440

Top paying metropolitan areas:

Sacramento—Arden-Arcade—Roseville, CA $102,360
San Jose-Sunnyvale-Santa Clara, CA $100,000
Lowell-Billerica-Chelmsford, MA-NH NECTA Division $99,010
Bridgeport-Stamford-Norwalk, CT $98,520
Wenatchee, WA $98,100

Industries with the highest level of employment:
(highest at top)

Professional and Commercial Equipment and Supplies Merchant Wholesalers
Wholesale Electronic Markets and Agents and Brokers
Drugs and Druggists’ Sundries Merchant Wholesalers
Electrical and Electronic Goods Merchant Wholesalers
Computer Systems Design and Related Services

Top paying industries:

Satellite Telecommunications $107,050
Other Professional, Scientific, and Technical Services $102,100
Other Motor Vehicle Dealers $97,980
Other Telecommunications $92,770
Computer and Peripheral Equipment Manufacturing $91,080

Training and requirements needed:

Today, more frequently then not, employers are hiring sales representatives with a college degree, regardless of the type of product you are selling. If you want to be a pharmaceutical sales representative, indeed you should have a college degree. As a matter of fact, in most cases, you need a college degree if you want to sell any technical or scientific product.

The usual characteristics of any successful salesman such as a friendly personality, the ability to sell, and familiarity with the brand are also looked for in the pharmaceutical sales representative. Also, more so then many other sales positions, you need to sell the product to the physician within a very short period of time, usually a matter of minutes. This is simply because most doctors do not not have the time to listen to a long sales pitch.

In the pharmaceutical industry, it is essential that the sales rep have a complete and thorough knowledge of the drug he or she is selling. This includes side effects, interactions, efficacy, clinical trial data and more. Therefore extensive knowledge from the disciplines of chemistry and human biology are essential, along with a thirst for learning and understanding. Knowledge about drugs and medicines is also picked up from seminars and on the job training.

For more information about training required for the pharmaceutical sales representative in the United States go to Occupational Outlook Handbook provided by the Bureau of Labor Statistics.

Pharmaceutical Sales Jobs – Employment Growth and Outlook

Overall, sales employment growth in the United States is expected to be about average. Employment growth is expected to be around 9% between 2006 and 2016, which is average relative to all other occupations. It should be noted that this is for all sales positions.

As the elderly population in the United States continues to grow in size, their need for various medicines will also continue to grow. Drug companies will need to produce medicines with a high level of efficacy and fewer side effects in order to meet the medical needs of an increasing elderly population. Because the pharmaceutical sales representative is the interfacing pipeline between the drug company and the physician, this type of sales representative should continue to see increasing employment opportunities. Therefore, employment growth for the pharmaceutical sales representative should be greater then that which is expected for other sales positions.

It should also be noted that competition for technical and scientific product sales positions will be keen, including pharmaceutical sales representatives. This is because of the higher salary offered to individuals who hold these positions.

Source for the above data:
Bureau of Labor Statistics



Help with your job search! Attract employers’ attention with a top-notch resume and cover letter! Get the help of a professional resume writer!

Pharmaceutical Sales Jobs Listed by State – Updated Daily

Vision Directed Interviews: How to Succeed within Interviews

You’ve probably read numerous job interview tips which list the ways to respond to the difficult interview questions: Tell me about Yourself; What are your work-related weaknesses?; Why are you leaving your current employer? These are the usual dreaded questions that we all expect to hear from interviewers. Typically interviewees are advised to create well-prepared and rehearsed scripts to respond to these dreaded questions. And so, during the course of the interview, interviewees sit on the edge of their seats waiting to respond, trying to remember the correct answers. And consequently, the interview becomes a race, a highly tense setting designed to stay one step ahead of the other with scripted conversation and pre-planned positioning and second-guessing. The possibility of authentically assessing the merits of the position and being able to evaluate how you might fit within the company’s culture and mission is minimized in this scenario. Go here to read this entire article

Free: An easier Way to Change Jobs

Pharmaceutical Industry News

Drugs.com - Pharma Industry News
Headline news from Drugs.com. Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Drugs.com Releases Q1 Sales for Top 100 U.S. Drugs: Rough U.S Flu Season Boosts Numbers for Tamiflu
NEW YORK, May 6, 2013 /PRNewswire/ — Drugs.com, the leading online clinical drug resource, today released first quarter 2013 U.S. prescription sales data for the top 100 drugs. The top five drugs have minor shifts in rank but exhibit positive...
Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication
Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion AUDIENCE: Risk Manager, Pharmacy, Oncology ISSUE: The FDA notified health care professionals that the use of...
Valproate Anti-Seizure Products: Drug Safety Communication
Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER),...
Hyperion Therapeutics Receives Orphan Drug Exclusivity From FDA
SOUTH SAN FRANCISCO, Calif., May 2, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the U.S. Food and Drug Administration (FDA) yesterday notified the company that RAVICTI(TM) (glycerol...
FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death
Safety Announcement [04-30-2013] The U.S. Food and Drug Administration (FDA) has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease...
FDA OKs OTC Plan B for 15 and Older
FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older The U.S. Food and Drug Administration today announced that it has approved an amended application submitted by Teva...
FDA Warns of Fake Botox
Fraudulent Versions of Botox Found in the United States [04-26-2013] FDA is alerting health care practitioners and the public that fraudulent versions of Botox that are not approved by the FDA are being sold to U.S. medical...
FDA Device to Detect Fake Malarial Drugs
FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool The U.S. Food and Drug Administration today announced a public-private partnership to help identify...
Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for...
Teva Neuroscience Gets FDA Letter Regarding Clozapine Promotion
SILVER SPRING, Md., April 23, 2013-The FDA yesterday posted on its website a letter sent to Teva Neuroscience regarding an article detailer for Clozapine tablets. The letter is below. Carol Childers Director Teva Neuroscience, Inc....
Sanofi Pasteur and KaloBios Pneumonia Drug Fast-Tracked
U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa CHICAGO, April 23, 2013 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and...
FDA recently approved changes to the Atripla
FDA recently approved changes to the Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablet label to include the following changes: • Lists Stribild as one of the drugs that should not be coadministered with...
Balanced Solutions Compounding Pharmacy Issues Voluntary Recall
All sterile non-expired products recalled due to a lack of sterility assurance Balanced Solutions Compounding Pharmacy (Balanced Solutions), a division of Axium Healthcare Pharmacy, Inc., of Lake Mary, Fla., is voluntarily...
Neura Therapeutik Addresses FDA Concerns about Abuse, Misuse of Drugs with Development of Safe and Affordable Abuse-Deterrent Opioids
FLEMINGTON, N.J., April 18, 2013 /PRNewswire/ -- Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids. This is in response to the Food and Drug...
Purdue Pharma Statement on FDA Approval of New Label for Reformulated OxyContin and FDA Decision Regarding Withdrawal of Original Formulation Due to Safety
Professional Prescribing Information Now Includes Language Describing Abuse-Deterrence Studies Conducted with the Reformulated Tablets April 16, 2013 – STAMFORD, Conn. – Purdue Pharma L.P. today announced that the U.S. Food...
FDA Approves Abuse-Deterrent Labeling for Reformulated OxyContin
Agency will not approve generics to original OxyContin April 16, 2013 -- The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.’s reformulated OxyContin (oxycodone hydrochloride controlled-release) tablets....
FDA Issues Alert for Sterility Issues for ApotheCure, Inc. and NuVision Pharmacy
FDA issues alert about lack of sterility assurance of drug products from ApotheCure, Inc. and NuVision Pharmacy and of forthcoming recall SILVER SPRING, Md., April 15, 2013--The U.S. Food and Drug Administration is alerting health care...
FDA Reviewing Heart Risks of Glaxo Diabetes Pill
WASHINGTON (AP) — The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia. Avandia was severely restricted in 2010 due to concerns about...
Drugs.com Receives Fourth Webby Nomination!
TUESDAY April 9, 2013 -- We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the...
FDA Approves Return of Drug for Morning Sickness
WASHINGTON (AP) — A treatment pulled off the market 30 years ago has won Food and Drug Administration approval as the only drug specifically designated to treat morning sickness. That long-ago safety scare proved to be a big false...
FDA OKs Novartis Tobi Podhaler
FDA Approves Novartis Tobi Podhaler for Certain Cystic Fibrosis Patients, the First and Only Dry Powder Inhaled Antibacterial in US    TOBI Podhaler is portable and requires no nebulizer, refrigeration or power source to deliver the...
93 new medicines: FDA during 2012 approved 39 new molecular entities, the highest amount in one year since 1997
U.S. regulators last year approved for marketing 93 new medicines according to Med Ad News criteria. This figure represents an additional 14 products versus the 2011 amount of 80. Previous years’ totals of new drug approvals by the Food and Drug...
Monthly News Round Up - March 2013
Tecfidera FDA-Approved for Multiple Sclerosis Multiple sclerosis (MS) is a central nervous system disease that disrupts communication between the brain and other parts of the body. MS, which results in muscle weakness and difficulty with...
Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection
AUDIENCE: Eye Care, Health Professional, Patient ISSUE: Clinical Specialties is voluntarily recalling Avastin unit dose syringes. The product has or potentially could result in an infection within the eye. Clinical Specialties has...
Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas
  AUDIENCE: Gastroenterology, Endocrinology, Oncology, Patient ISSUE: FDA is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis and pre-cancerous cellular changes called...
Generic Drugs Will Hit Pharmaceuticals Hard in 2013
From Benzinga Lightning Feed (March 14, 2013) On Wednesday, Spectrum Pharmaceuticals (NASDAQ: SPPI) dropped 37 percent after releasing its Q1 and full year revenue guidance. The company said it expects sales of its colorectal cancer drug, Fusilev,...
Azithromycin (Zithromax or Zmax): Drug Safety Communication - Risk of Potentially Fatal Heart Rhythms
AUDIENCE: Family Practice, Patient, Pharmacy, Health Professional ISSUE: FDA is warning the public that azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal...
Interpol and Pharmaceutical Industry Launch Global Initiative to Combat Fake Medicines
LYON, France – Combating the global scourge of fake medicines which threatens the health of millions of people is the focus of a landmark agreement between INTERPOL and 29 of the world’s largest pharmaceutical companies. The three-year...
$3.6 Million in Fake Prescription Drugs Seized in South Carolina
$3.6 Million in Fake Prescription Drugs Seized in Columbia [the Post and Courier, Charleston, S.C.] From Post & Courier (Charleston, SC) (March 10, 2013) March 09--Some $3.6 million in bogus prescription drugs, including Viagra, Cialis and...
Handwritten Scripts Still Outpace E-Prescribing by More than 60 Percent, According to New Data
MediScripts Prescribers Write Nearly 1 Billion Pen-and-Pad Scripts in 2012 HASBROUCK HEIGHTS, NJ, February 28, 2013 – MediScripts, a point-of-prescription advertising medium, today announced that its proprietary database of MediScripts...
Research Uncorks Answer on Wine and Antiaging Process
Research Uncorks Answer on Wine and Antiaging Process [the Philadelphia Inquirer] From Philadelphia Inquirer (PA) (March 8, 2013) March 08--Remember the fanfare a while back about a compound in red wine that seemed to extend the life span of bees,...
Drugs.com Launches iOS and Android Mobile App to Empower Patients and Providers Alike
Clean lines and an instinctive user interface frames a practical prescription management tool for consumers on-the-go. NEW YORK, March. 8, 2013 -- Drugs.com, the leading online clinical drug resource, today announced they have launched the...
Dr. Reddy's Announces the Launch of Zoledronic Acid Injection
HYDERABAD, India--(BUSINESS WIRE)--Mar 5, 2013 - Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Zometa® (zoledronic acid) 4 mg/5 mL Injection in...
Ranbaxy to Market Desvenlafaxine Base Extended Release Tablets in the U.S.
PRINCETON, N.J., March 5, 2013 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has entered into an in-licensing agreement with Alembic Pharmaceuticals...
Ranbaxy Labs Says It Will Sell Generic Pristiq
From Associated Press (March 5, 2013) NEW YORK -- Ranbaxy Laboratories Ltd. said Tuesday it will start selling a generic version of Pfizer Inc.’s antidepressant Pristiq before the end of March. The Indian drug maker said it acquired the...
J&J Says FDA Denies New Xarelto Application
From Associated Press (March 5, 2013) NEW YORK -- Johnson & Johnson said Monday that regulators have again refused to grant a new marketing approval to its anticlotting drug Xarelto. The company has asked the Food and Drug Administration...
FDA Panel Rejects Depomed Menopause Treatment
From Associated Press (March 4, 2013) WASHINGTON -- Shares of Depomed slid Friday after a panel of advisers to the Food and Drug Administration overwhelmingly voted against its drug to treat hot flashes and other symptoms of menopause. The FDA...
Express Scripts Report Shows Spending on Traditional Medicines Fell in 2012
Express Scripts Report Shows Spending on Traditional Medicines Fell in 2012 [St. Louis Post-Dispatch] From St. Louis Post-Dispatch (MO) (March 5, 2013) March 05--For the first time in more than 20 years, there was a decrease last year in U.S....
Panic and Chaos in Pharmacies As Greece Runs Low on Hundreds of Medicines
Multinational companies accused of cutting supply Low prices and unpaid state debts being blamed From Guardian (UK) (February 28, 2013) Greece is facing a serious shortage of medicines amid claims that pharmaceutical multinationals have halted...
FDA Suspends Pediatric Clinical Trials After Report Of Death
Sensipar (Cinacalcet Hydrochloride): Drug Safety Communication - FDA Suspends Pediatric Clinical Trials After Report Of Death   AUDIENCE: Health Professional, Endocrinology, Pediatrics ISSUE: FDA has stopped all pediatric clinical trials of...

7r5wk2sayt

Human Resources Directory

List your business in premium web directories . This website is listed under Job Search Directory

Powered by FirstRSS Plugin